Personalized medicine, says this article in The Scientist, could breathe new life into failed drug candidates. "If Merck could have known in advance who would have cardiovascular problems from Vioxx, they may not have had to withdraw it from the market," Personalized Medicine Coalition's Edward Abrahams says.